-
Adding an organ donation option to the average Facebook user's profile prompted a dramatic rise in potential donors, researchers report.More Adding an organ donation option to the average Facebook user's profile prompted a dramatic rise in potential donors, researchers report.More Children of women who drink moderate amounts of alcohol while pregnant don't appear to have any neurodevelopmental problems when it comes to balance, a new British study suggests.More Children of women who drink moderate amounts of alcohol while pregnant don't appear to have any neurodevelopmental problems when it comes to balance, a new British study suggests.More Concussion can lead to damage in the white matter of the brain that resembles abnormalities found in people in the early stages of Alzheimer's disease, a new study suggests.More Concussion can lead to damage in the white matter of the brain that resembles abnormalities found in people in the early stages of Alzheimer's disease, a new study suggests.More Plenty of Americans are eager to use their mobile phones and tablet computers to better manage their health care, a new poll finds -- though the nation has a way to go before we're all consulting Dr. Smartphone.More Plenty of Americans are eager to use their mobile phones and tablet computers to better manage their health care, a new poll finds -- though the nation has a way to go before we're all consulting Dr. Smartphone.More
THURSDAY, Aug. 30 (HealthDay News) -- Linzess (linaclotide) has been approved by the U.S. Food and Drug Administration to treat forms of chronic constipation that don't respond to traditional treatment, and irritable bowel syndrome accompanied by constipation, the agency said Thursday in a news release.
The National Institutes of Health estimates that some 63 million people are affected by chronic constipation, and about 15.3 million have irritable bowel syndrome (IBS), the FDA said.
Linzess is taken once daily on an empty stomach, at least 30 minutes before the first meal. The most frequently noted adverse reaction is diarrhea.
The drug's label contains a boxed warning that it shouldn't be taken by people aged 16 or younger, the FDA said.
Linzess is produced by Cambridge, Mass.-based Ironwood Pharmaceuticals.
More information
Medline Plus has more about constipation.

Copyright © 2012 HealthDay. All rights reserved.